University of Alabama Child Health Research Unit
Welcome,         Profile    Billing    Logout  
 5 Trials 
22 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hathorne, Heather R
NCT03624101: Novel Therapeutic Approaches for Treatment of CF Patients with W1282X Premature Termination Codon Mutations

Completed
4
2
US
Trikafta, symdeko/Trikafta, Ivacaftor/Trikafta
University of Alabama at Birmingham
Cystic Fibrosis
12/24
12/24
STOP360AG, NCT05548283: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Recruiting
4
730
Canada, US
Beta-lactam antibiotic, β-lactam, Aminoglycoside, AG
Chris Goss, University of Washington, Medical University of South Carolina, Cystic Fibrosis Foundation
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
11/26
11/26
ICoN-1, NCT06418711: Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Recruiting
3
234
US
Clofazimine Inhalation Suspension, MNKD-101, Placebo
Mannkind Corporation
MAC Lung Disease, Treatment Refractory MAC Lung Disease, Mycobacterium Infections, Nontuberculous
08/26
12/28
NCT05495243: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

Completed
2
40
US
ARINA-1, Placebo
Renovion, Inc.
Non-cystic Fibrosis Bronchiectasis
02/24
02/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis

Recruiting
1/2
40
US
4D-710
4D Molecular Therapeutics
Cystic Fibrosis Lung
12/26
01/30
NCT03587961: Personalized Theratyping Trial

Recruiting
1
20
US
Symdeko, Orkambi, Ivacaftor
University of Alabama at Birmingham
Cystic Fibrosis
01/26
09/26
NCT04075864: Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis

Recruiting
N/A
12
US
Behavioral Counseling and Exercise
University of Alabama at Birmingham
Cystic Fibrosis
12/25
12/26
NCT03256773: High Resolution Micro OCT Imaging

Recruiting
N/A
60
US
University of Alabama at Birmingham, Massachusetts General Hospital
Cystic Fibrosis, COPD, PCD - Primary Ciliary Dyskinesia, Covid19, Sinusitis
12/24
12/24
CHEC-SC, NCT03350828: CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes

Active, not recruiting
N/A
5000
US
Nicole Hamblett, Cystic Fibrosis Foundation
Cystic Fibrosis
12/26
12/26
NCT06504589: A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting
N/A
400
US
Nicole Hamblett, Washington University School of Medicine, Florida State University, University of North Carolina, Chapel Hill, University of Toronto, Cystic Fibrosis Foundation
Cystic Fibrosis
08/29
08/29
RARE, NCT03161808: Rare CFTR Mutation Cell Collection Protocol

Recruiting
N/A
500
US
George Solomon, Cystic Fibrosis Foundation
Cystic Fibrosis
12/25
12/26
NCT04680403: Video Telehealth Exercise Training in Cystic Fibrosis

Recruiting
N/A
25
US
Exercise, Behavior Change Coaching
University of Alabama at Birmingham
Cystic Fibrosis
01/26
12/27
BEGIN, NCT04509050: Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

Recruiting
N/A
210
US
Ivacaftor or elexacaftor/tezacaftor/ivacaftor, Kalydeco or Trikafta, Vertex (VX)-770 or VX-445/VX-661/VX-770
Sonya Heltshe, Cystic Fibrosis Foundation, University of Washington, University of Alabama at Birmingham
Cystic Fibrosis
12/29
12/29
MAYFLOWERS, NCT04828382: Prospective Study of Pregnancy in Women with Cystic Fibrosis

Active, not recruiting
N/A
285
US
Amalia Magaret, University of Texas, National Jewish Health, Cystic Fibrosis Foundation
Pregnancy Related, Cystic Fibrosis
12/26
12/26
Solomon, George M
BMX-04-001, NCT05010577 / 2022-003810-35: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Active, not recruiting
1b/2a
32
Europe, US, RoW
BX004-A, Bacteriophage, Placebo, Vehicle buffer
BiomX, Inc., BiomX Ltd.
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis
10/23
03/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis

Recruiting
1/2
40
US
4D-710
4D Molecular Therapeutics
Cystic Fibrosis Lung
12/26
01/30
NCT03587961: Personalized Theratyping Trial

Recruiting
1
20
US
Symdeko, Orkambi, Ivacaftor
University of Alabama at Birmingham
Cystic Fibrosis
01/26
09/26
HFCWO, NCT04271969: Clinical Effectiveness Of High Frequency Chest Wall Oscillation () In A Bronchiectasis Population

Completed
N/A
25
US
SmartVest Airway Clearance System
Electromed, Inc., University of Alabama at Birmingham
Bronchiectasis
12/23
12/23
HOPeCF, NCT06296394: Health Outcomes of Parents With Cystic Fibrosis-Aim 2

Recruiting
N/A
146
US
Parenthood
University of Pittsburgh, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis, Parenthood Status
02/30
02/31
RARE, NCT03161808: Rare CFTR Mutation Cell Collection Protocol

Recruiting
N/A
500
US
George Solomon, Cystic Fibrosis Foundation
Cystic Fibrosis
12/25
12/26
Anderson, Justin
NCT05495243: Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Excess Mucus and Cough

Completed
2
40
US
ARINA-1, Placebo
Renovion, Inc.
Non-cystic Fibrosis Bronchiectasis
02/24
02/24
AEROW, NCT05248230: 4D-710 in Adult Patients with Cystic Fibrosis

Recruiting
1/2
40
US
4D-710
4D Molecular Therapeutics
Cystic Fibrosis Lung
12/26
01/30

Download Options